STATE STREET CORP - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 71 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2017. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$87,408
+34.5%
791,026
+100.0%
0.00%
Q3 2022$65,000
-35.0%
395,5130.0%0.00%
Q2 2022$100,000
-52.4%
395,5130.0%0.00%
Q1 2022$210,000
-4.5%
395,513
+10.7%
0.00%
Q4 2021$220,000
-39.6%
357,2090.0%0.00%
Q3 2021$364,000
-43.6%
357,209
+1.3%
0.00%
Q2 2021$645,000
-78.9%
352,709
-77.2%
0.00%
Q1 2021$3,053,000
+83.1%
1,549,815
+16.2%
0.00%
Q4 2020$1,667,000
-94.4%
1,333,546
-92.0%
0.00%
-100.0%
Q3 2020$29,913,000
+17.0%
16,618,149
+445.6%
0.00%0.0%
Q2 2020$25,557,000
+321.7%
3,046,084
+163.4%
0.00%
+100.0%
Q1 2020$6,061,000
-1.0%
1,156,624
+3.1%
0.00%
Q4 2019$6,124,000
+14.4%
1,121,673
+2.0%
0.00%
Q3 2019$5,355,000
-25.8%
1,099,507
+5.6%
0.00%
-100.0%
Q2 2019$7,214,000
+11.4%
1,040,960
+11.7%
0.00%0.0%
Q1 2019$6,475,000
+25.4%
931,657
+5.4%
0.00%
Q4 2018$5,163,000
-21.7%
884,115
+1.3%
0.00%
-100.0%
Q3 2018$6,590,000
+63.5%
872,406
+9.3%
0.00%
Q2 2018$4,031,000
-17.1%
797,955
+0.1%
0.00%
Q1 2018$4,861,000
-2.6%
797,146
+13.4%
0.00%
Q4 2017$4,993,000
+4.9%
702,868
+5.6%
0.00%
Q3 2017$4,761,000
+28.4%
665,831
+13.1%
0.00%
Q2 2017$3,708,000
+2276.9%
588,662
+2998.2%
0.00%
Q1 2017$156,000
-4.9%
19,000
-2.1%
0.00%
Q4 2016$164,000
+24.2%
19,4000.0%0.00%
Q3 2016$132,00019,4000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q2 2017
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,738,925$23,555,00031.22%
Perceptive Advisors 1,232,500$7,764,0000.39%
IFP Advisors, Inc 1,001,025$6,306,0000.27%
WOODSTOCK CORP 55,489$350,0000.07%
Virtus ETF Advisers LLC 50,795$320,0000.05%
Dynamic Technology Lab Private Ltd 31,431$198,0000.04%
Evanson Asset Management, LLC 20,660$130,0000.03%
Artal Group S.A. 250,000$1,575,0000.03%
GSA CAPITAL PARTNERS LLP 58,800$370,0000.02%
Raymond James Financial Services Advisors, Inc. 426,280$2,686,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders